Skip to main content
Premium Trial:

Request an Annual Quote

IP Holdings Founds New Company to Commercialize Applications for Human Gene

NEW YORK, April 5 (GenomeWeb News) - IP Holdings, a business incubator in Suffern, New York, has founded a company, Ryogen, that aims at commercializing applications for a recently patented human gene.


According to IP Holdings, the IP, which centers on the XPNPEP2 gene, "pertains to extensive segments of the human genome sequence and its applications to microarray manufacturing, gene testing and development of therapeutic agents."

The gene codes for the protein membrane-bound aminopeptidase P (AmP). The gene has received a US Patent, No. 6,399,349, entitled "Human Aminopeptidase P Gene."


IP Holdings claims the gene is a marker for hypertension, angioedema, rejection of kidney transplants, and certain tumors. The patent covers cDNA and gDNA sequences coding AmP; a method of producing AmP; the diagnostics for detecting AmP abnormalities; and prevention and treatment of medical conditions associated with the mutation of the AmP gene, IP Holdings said.


"We plan to pursue a comprehensive licensing program to ensure the broad proliferation of Ryogen's IP," said Alexander Poltorak, managing director of IP Holdings.

Ryogen is exploring a number of alternatives to license the AmP patent, including "ways to make this gene widely available for research so as to promote the development of genetic testing and treatment.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.